Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
Clinical trial NCT06520397 · RECRUITING
Trial details
- NCT number
- NCT06520397
- Sponsor
- Sixth Affiliated Hospital, Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-15
- Primary completion
- 2026-12-31
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.